Zhang Z, Pang J, Chen L, Chen J, et al. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas. Hum Pathol 2022;129:21-31.
PMID: 35977594